Active Anticancer Treatment Associated With Poor COVID-19 Prognosis
Patients with cancer are more susceptible to infection with SARS-CoV-2, and patients receiving active anticancer treatment have a poorer prognosis.
General Hematology
Genetic Tests May Differ in Their Interpretation of Certain Variants
Eleven percent of interpretations were different for TP53 gene; difference can impact management.
COVID-19 Drug Remdesivir Could Cost Up to $3120 Per Patient
In the US, government programs, additional Gilead assistance should mean all patients have access to the drug.
Methotrexate-Induced Acute Kidney Injuries in Patients with Hematologic Malignancies
Upon starting methotrexate treatment, LDH and albumin levels may be signals for AKIs in patients with hematologic malignancies.
Effects of Givosiran in Acute Intermittent Porphyria
Givosiran improved the rate of porphyria attacks in patients with acute intermittent porphyria compared with placebo.
Age, Residence, Other Factors Associated With Palliative Care Consultations in Patients With Advanced Cancer
Several factors were found to affect whether patients with cancer received a palliative care consultation at a tertiary care center.
African-American Participation Inadequate in Cancer Drug Trials
Consistent underrepresentation seen in clinical trials evaluating medications across major cancer types.
Ruxolitinib in Glucocorticoid-Refractory Acute Graft-vs-Host Disease After Allogeneic Stem Cell Transplantation
For patients with GVHD, ruxolitinib improves efficacy outcomes compared with 9 other commonly used options.
First Guidelines for Providing Oncology Pharmacy Services in COVID-19
The first set of guidelines for providing oncology pharmacy services to cancer patients during the COVID-19 pandemic was recently published.
US Medical Cancer Care Costs Substantial, Expected to Increase
Costs of care for patients with cancer was found to vary based on stage and site of disease.
-
Loading...
-
Loading...
Next post in General Hematology
